A live model to study mucociliary clearance in health and disease
研究健康和疾病中粘液纤毛清除的实时模型
基本信息
- 批准号:NC/S001034/1
- 负责人:
- 金额:$ 62.96万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2018
- 资助国家:英国
- 起止时间:2018 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The human lungs are the sites of gaseous exchange where air, containing oxygen, is breathed in and carbon dioxide is breathed out. This direct interaction with the outside world makes the lungs particularly vulnerable to the entry of harmful foreign agents such as pollutants and bacteria, viruses and fungi. In order to prevent their entry into the body, a protective barrier shields the exposed surfaces of the lungs. This barrier is composed of mucus, a gel-like material that acts like a 'molecular sieve' to trap inhaled infectious agents and pollutants. Once trapped, these foreign bodies need to be removed from the lung before they cause damage. Specific lung cells, called ciliated cells, project tiny hair-like structures (cilia) into the overlying mucus layer. The cilia move together in a coordinated manner so as to generate a directional flow that takes the mucus, and any trapped material, away from the lungs. This process is known as mucociliary clearance and if it is defective this can lead to disease. Examples of diseases with defective mucociliary clearance includes cystic fibrosis, where mucus is thick and sticky and cannot be moved; asthma, where an overproduction of mucus can cause airway obstruction; and primary ciliary dyskinesia where cilia movement is impaired and so mucus cannot be cleared. These diseases, particularly cystic fibrosis and primary ciliary dyskinesia, lead to increase vulnerability to infection, which can prove fatal.In order to effectively treat these diseases, we need to understand precisely how mucociliary clearance works so that we can design drugs to improve outcomes for patients. Scientists often employ model organisms to understand the details of a biological process that is difficult, or ethically improper, to study in humans. With mucociliary clearance, mammalian models, particularly mice, are commonly used to either mimic diseases or to understand the role of particular genes in the process. However, the anatomical location of the lungs within the body means that it is difficult to study the dynamics of mucociliary clearance and often involves invasive techniques that can be harmful to the mice. In this research proposal, we introduce an alternative model, the tadpole of the frog species, Xenopus tropicalis, to replace the use of mice in these studies. Importantly, their skin surface produces mucus and has ciliated cells that move the mucus, just like in the human lungs. Details about the function of particular genes in mucociliary clearance and how mucus interacts with cilia and with other agents (e.g. bacteria) can be elucidated with this model, extending our understanding of mucociliary clearance in humans. Crucially, the tadpoles that we use are at an early developmental stage and are considered to be non-sentient. Our aim for this project is to develop and validate this live model of mucociliary clearance using the tadpole skin in order to gain new scientific insight at the same time as replacing, and reducing the reliance on, mice.
人体的肺部是气体交换的场所,吸入含有氧气的空气并呼出二氧化碳。这种与外界的直接相互作用使肺部特别容易受到污染物、细菌、病毒和真菌等有害外来物质的影响。为了防止它们进入体内,保护屏障保护了肺部的暴露表面。该屏障由粘液组成,粘液是一种凝胶状材料,其作用类似于“分子筛”,可捕获吸入的传染源和污染物。一旦被困,这些异物需要在造成损害之前从肺部清除。特定的肺细胞(称为纤毛细胞)将微小的毛发状结构(纤毛)投射到上面的粘液层中。纤毛以协调的方式一起移动,从而产生定向流动,将粘液和任何截留的物质带离肺部。这个过程被称为粘膜纤毛清除,如果它有缺陷,就会导致疾病。粘液纤毛清除有缺陷的疾病的例子包括囊性纤维化,其中粘液浓稠且粘稠且无法移动;哮喘,粘液分泌过多会导致气道阻塞;原发性纤毛运动障碍,纤毛运动受损,因此粘液无法清除。这些疾病,特别是囊性纤维化和原发性纤毛运动障碍,会导致感染的可能性增加,这可能是致命的。为了有效治疗这些疾病,我们需要准确了解粘膜纤毛清除的工作原理,以便我们可以设计药物来改善患者的治疗结果。科学家经常利用模型生物来了解生物过程的细节,而这些生物过程在人类身上进行研究是困难的,或者在伦理上是不恰当的。通过粘液纤毛清除,哺乳动物模型,特别是小鼠,通常用于模拟疾病或了解特定基因在此过程中的作用。然而,肺部在体内的解剖位置意味着很难研究粘膜纤毛清除的动态,并且通常涉及可能对小鼠有害的侵入性技术。在本研究提案中,我们引入了另一种模型,即青蛙物种热带爪蟾的蝌蚪,以取代这些研究中使用的小鼠。重要的是,它们的皮肤表面会产生粘液,并具有移动粘液的纤毛细胞,就像人类的肺部一样。通过该模型可以阐明特定基因在粘液纤毛清除中的功能以及粘液如何与纤毛和其他物质(例如细菌)相互作用的细节,从而扩展我们对人类粘液纤毛清除的理解。至关重要的是,我们使用的蝌蚪正处于早期发育阶段,被认为是没有知觉的。我们该项目的目标是开发和验证这种使用蝌蚪皮肤进行粘膜纤毛清除的活体模型,以便在替代小鼠并减少对小鼠的依赖的同时获得新的科学见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Thornton其他文献
Dynamic Protective Factors Relevant to Sexual Offending
- DOI:
10.1007/s11920-024-01493-5 - 发表时间:
2024-02-24 - 期刊:
- 影响因子:6.700
- 作者:
David Thornton;Gwenda M. Willis;Sharon Kelley - 通讯作者:
Sharon Kelley
Therapist characteristics in the treatment of sexual offenders: Tentative data on their relationship with indices of behaviour change
治疗性犯罪者的治疗师特征:关于其与行为改变指数关系的初步数据
- DOI:
- 发表时间:
2003 - 期刊:
- 影响因子:0
- 作者:
William L. Marshall;G. Serran;Y. Fernandez;R. Mulloy;Ruth E. Mann;David Thornton - 通讯作者:
David Thornton
Evidence Regarding the Need for a Diagnostic Category for a Coercive Paraphilia
- DOI:
10.1007/s10508-009-9583-6 - 发表时间:
2009-11-26 - 期刊:
- 影响因子:2.900
- 作者:
David Thornton - 通讯作者:
David Thornton
Assembly of Tim9 and Tim10 into a Functional Chaperone*
将 Tim9 和 Tim10 组装成功能伴侣*
- DOI:
10.1074/jbc.m202310200 - 发表时间:
2002 - 期刊:
- 影响因子:0
- 作者:
S. Vial;Hui Lu;S. Allen;P. Savory;David Thornton;J. Sheehan;K. Tokatlidis - 通讯作者:
K. Tokatlidis
Advances in the Assessment of Sexual Deviance
- DOI:
10.1007/s11920-018-0918-7 - 发表时间:
2018-07-21 - 期刊:
- 影响因子:6.700
- 作者:
David Thornton;Gina Ambroziak;Rachel E. Kahn;James Mundt - 通讯作者:
James Mundt
David Thornton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Thornton', 18)}}的其他基金
Defining the mechanisms controlling mucus function
定义控制粘液功能的机制
- 批准号:
BB/W006456/1 - 财政年份:2022
- 资助金额:
$ 62.96万 - 项目类别:
Research Grant
Sustainable Energy Engineering for Empowering Rural Communities
赋权农村社区的可持续能源工程
- 批准号:
1953601 - 财政年份:2020
- 资助金额:
$ 62.96万 - 项目类别:
Standard Grant
Unravelling the molecular mechanisms controlling respiratory tract mucus gel formation in health and disease
揭示健康和疾病中控制呼吸道粘液凝胶形成的分子机制
- 批准号:
MR/R002800/1 - 财政年份:2017
- 资助金额:
$ 62.96万 - 项目类别:
Research Grant
Defining mechanisms of mucosal innate defence using the X. tropicalis tadpole
使用热带蝌蚪定义粘膜先天防御机制
- 批准号:
BB/M021688/1 - 财政年份:2015
- 资助金额:
$ 62.96万 - 项目类别:
Research Grant
Defining the functional roles of MUC5AC and MUC5B in mucus in respiratory airways
定义呼吸道粘液中 MUC5AC 和 MUC5B 的功能作用
- 批准号:
G1000450/1 - 财政年份:2010
- 资助金额:
$ 62.96万 - 项目类别:
Research Grant
Investigation of a novel supramolecular organisation of the oligomeric mucins MUC5AC MUC5B and MUC2
寡聚粘蛋白 MUC5AC MUC5B 和 MUC2 的新型超分子组织的研究
- 批准号:
BB/D522389/1 - 财政年份:2006
- 资助金额:
$ 62.96万 - 项目类别:
Research Grant
相似国自然基金
基于术中实时影像的SAM(Segment anything model)开发AI指导房间隔穿刺位置决策的增强现实模型
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
运用3D打印和生物反应器构建仿生尿道模型探索Hippo-YAP信号通路调控尿道损伤修复的机制研究
- 批准号:82370684
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
- 批准号:82371912
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
- 批准号:
- 批准年份:2020
- 资助金额:40 万元
- 项目类别:
半参数空间自回归面板模型的有效估计与应用研究
- 批准号:71961011
- 批准年份:2019
- 资助金额:16.0 万元
- 项目类别:地区科学基金项目
高频数据波动率统计推断、预测与应用
- 批准号:71971118
- 批准年份:2019
- 资助金额:50.0 万元
- 项目类别:面上项目
人胆囊源CD63+细胞的干性特征与分化特性的研究
- 批准号:31970753
- 批准年份:2019
- 资助金额:52.0 万元
- 项目类别:面上项目
基于线性及非线性模型的高维金融时间序列建模:理论及应用
- 批准号:71771224
- 批准年份:2017
- 资助金额:49.0 万元
- 项目类别:面上项目
应用Agent-Based-Model研究围术期单剂量地塞米松对手术切口愈合的影响及机制
- 批准号:81771933
- 批准年份:2017
- 资助金额:50.0 万元
- 项目类别:面上项目
凯莱流形上的几何流
- 批准号:11771301
- 批准年份:2017
- 资助金额:48.0 万元
- 项目类别:面上项目
相似海外基金
Comprehensive characterization of immune signaling networks in single-cells by joint quantification of proteins, protein complexes and mRNA
通过蛋白质、蛋白质复合物和 mRNA 的联合定量来全面表征单细胞中的免疫信号网络
- 批准号:
10636695 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
Systems Approaches to Understanding the Impact of Cell-Cell Fusion on Therapeutic Resistance
了解细胞间融合对治疗耐药性影响的系统方法
- 批准号:
10607123 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
ELUCIDATING THE ROLE OF COATOMER COMPLEX COPI IN SKELETAL DYSPLASIA
阐明 COATOMER 复合物 COPI 在骨骼发育不良中的作用
- 批准号:
10591042 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
Engineering Human Organizer To Study Left-Right Symmetry Breaking
工程人类组织者研究左右对称性破缺
- 批准号:
10667938 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
Spatial and Single Cell Transcriptomics Approach to Understand Neuron-Oligodendrocyte Communication in Human Synaptic Development
了解人类突触发育中神经元-少突胶质细胞通讯的空间和单细胞转录组学方法
- 批准号:
10646970 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
An Engineered Hydrogel Platform to Improve Neural Organoid Reproducibility for a Multi-Organoid Disease Model of 22q11.2 Deletion Syndrome
一种工程水凝胶平台,可提高 22q11.2 缺失综合征多器官疾病模型的神经类器官再现性
- 批准号:
10679749 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
Mechanisms of gene expression regulation in pancreatic cancer
胰腺癌基因表达调控机制
- 批准号:
10743387 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别:
Using natural killer cells to prevent breast cancer metastases
使用自然杀伤细胞预防乳腺癌转移
- 批准号:
10591362 - 财政年份:2023
- 资助金额:
$ 62.96万 - 项目类别: